Thank you for visiting the Astellas Pharma Inc. Website.
You will enter external sites beyond here.
(This link opens in a new window)
Basic Policy on Shareholder Return:
The Company is committed to sustained improvement in its enterprise value, leading to improved return to shareholders. While putting priority on investment to assure future growth, the Company will continuously increase dividend payments assuming improvement in medium- to long-term earnings on a consolidated basis considering dividend on equity attributable to owners of parent (DOE) and other factors, and also implement share buybacks in a flexible manner to improve capital efficiency and raise the level of return to shareholders.
Dividend
Record Date for Dividend:
Year-end dividend - March 31 Interim dividend - September 30
Historical Data of Dividend and DOE
| IFRS | ||||
|---|---|---|---|---|
| Dividend (Unit: Yen / share) | DOE (%) | |||
| Interim dividend |
Year-end dividend |
Annual dividend |
Annual DOE |
|
| Fiscal 2018 | 19 (planned) |
19 (planned) |
38 (planned) |
|
| Fiscal 2017 | 18 | 18 | 36 | 5.7 |
| Fiscal 2016 | 17 | 17 | 34 | 5.6 |
| Fiscal 2015 | 16 | 16 | 32 | 5.4 |
| Fiscal 2014 | 14 | 16 | 30 | 5.1 |
Notes: The Astellas Group has adopted the International Financial Reporting Standards ("IFRS"), effective from the fiscal year ended March 31, 2014.
Notes: The Company conducted a stock split of common stock at a ratio of 5 for 1 with an effective date of April 1,2014. The dividends per share is calculated based on the number of issued shares after the stock split （excluding treasury shares）on the assumption that the stock split was conducted at the beginning of FY2013.
Notes: In accordance with the Company's Articles of Incorporation, if cash dividends are not claimed for three (3) full years from the day of commencement of payment, the Company shall be relieved of the obligation to make such payment.
Share Buyback and Cancellation of Treasury Stock
| Acquisition period |
Shares acquired | Total acquisition cost (thousand yen) |
|
|---|---|---|---|
| Feb. 1 - Mar. 23 2018 |
39,577,500 | 59,999,993 |
|
| Jul. 31 - Oct. 31 2017 |
49,298,000 | 69,999,960 |
|
| Feb. 1 - Mar. 22 2017 |
30,000,000 | 45,525,514 |
|
| Oct. 31 - Dec. 22 2016 |
30,000,000 | 45,895,995 |
|
| Feb. 1 - Mar. 1 2016 |
17,000,000 | 27,455,199 |
|
| Nov. 2 - Dec. 1 2015 |
16,000,000 | 27,979,393 |
|
| Aug. 3 - Aug. 26 2015 |
15,000,000 | 28,211,012 |
|
| May. 28 - Jul. 10 2015 |
20,000,000 | 35,619,462 |
|
| Feb. 3 - Mar. 13 2015 |
15,000,000 | 28,214,129 |
|
| Nov. 5 - Dec. 12 2013 |
5,037,500 | 29,999,950 |
|
| Feb. 4 - Mar. 18 2013 |
6,000,000 | 29,847,367 |
|
| Nov. 5 - Dec. 10 2012 |
4,800,000 | 19,524,140 |
|
| Nov. 9 - Dec. 11 2009 |
8,200,000 | 26,961,398 |
|
| Nov. 7 - Dec. 12 2008 |
9,000,000 | 35,068,665 |
|
| Aug. 4 - Aug. 21 2008 |
10,000,000 | 48,351,108 |
|
| May. 15 - Jun. 20 2008 |
9,085,500 | 39,999,735 |
|
| Dec. 3 - Jan. 18 2008 |
8,000,000 | 38,684,248 |
|
| Aug. 29 - Sep. 10 2007 |
8,300,000 | 43,088,442 |
|
| Oct. 5 - Dec. 19 2006 |
29,046,300 | 149,999,577 |
|
| Aug. 2 - Sep. 20 2006 |
14,985,400 | 69,911,303 |
|
| Nov. 8 - Dec. 8 2005 |
5,979,300 | 26,999,916 |
|
| Aug. 3 - Aug. 31 2005 |
5,000,000 | 19,172,363 |
|
| Date of cancellation | Shares cancelled | Shares cancelled as a percentage of all outstanding shares issued prior to the cancellation |
|
|---|---|---|---|
| May 31, 2018 | 89,000,000 | 4.30% |
|
| May 31, 2017 | 85,000,000 | 3.95% |
|
| June 20, 2016 | 68,000,000 | 3.06% |
|
| May 29, 2015 | 38,000,000 | 1.68% |
|
| May 30, 2014 | 25,000,000 | 1.09% |
|
| May 31, 2013 | 11,000,000 | 2.40% |
|
| May 31, 2010 | 8,000,000 | 1.68% |
|
| June 23, 2009 | 28,000,000 | 5.56% |
|
| June 24, 2008 | 15,000,000 | 2.89% |
|
| June 26, 2007 | 45,000,000 | 7.98% |
|
| May 31, 2006 | 10,000,000 | 1.74% |
|
